BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,065 filers reported holding BAXTER INTL INC in Q2 2019. The put-call ratio across all filers is 1.42 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $4,000 | -69.2% | 46 | -69.5% | 0.00% | -66.7% |
Q1 2021 | $13,000 | +8.3% | 151 | 0.0% | 0.01% | 0.0% |
Q4 2020 | $12,000 | 0.0% | 151 | 0.0% | 0.01% | 0.0% |
Q3 2020 | $12,000 | -7.7% | 151 | 0.0% | 0.01% | -14.3% |
Q2 2020 | $13,000 | -27.8% | 151 | -31.7% | 0.01% | -36.4% |
Q1 2020 | $18,000 | -5.3% | 221 | 0.0% | 0.01% | +22.2% |
Q4 2019 | $19,000 | -98.2% | 221 | -98.1% | 0.01% | -98.1% |
Q3 2019 | $1,035,000 | +6.7% | 11,837 | 0.0% | 0.48% | +6.5% |
Q2 2019 | $970,000 | +0.8% | 11,837 | 0.0% | 0.45% | +7.5% |
Q1 2019 | $962,000 | +23.5% | 11,837 | 0.0% | 0.42% | +13.1% |
Q4 2018 | $779,000 | -14.6% | 11,837 | +0.1% | 0.37% | +7.6% |
Q3 2018 | $912,000 | +5.1% | 11,823 | +0.5% | 0.34% | -5.3% |
Q2 2018 | $868,000 | +13.5% | 11,767 | 0.0% | 0.36% | +63.6% |
Q1 2018 | $765,000 | +0.5% | 11,767 | 0.0% | 0.22% | -1.3% |
Q4 2017 | $761,000 | +3.1% | 11,767 | 0.0% | 0.22% | -10.1% |
Q3 2017 | $738,000 | +4.5% | 11,767 | +0.9% | 0.25% | -1.2% |
Q2 2017 | $706,000 | +513.9% | 11,662 | +628.9% | 0.25% | +332.8% |
Q3 2014 | $115,000 | -11.5% | 1,600 | -11.1% | 0.06% | -6.5% |
Q2 2014 | $130,000 | -1.5% | 1,800 | 0.0% | 0.06% | +47.6% |
Q1 2014 | $132,000 | -57.1% | 1,800 | -59.3% | 0.04% | -60.7% |
Q4 2013 | $308,000 | +3.7% | 4,425 | -2.2% | 0.11% | -4.5% |
Q3 2013 | $297,000 | -11.1% | 4,525 | -6.2% | 0.11% | -6.7% |
Q2 2013 | $334,000 | – | 4,825 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |